TrialFind
Saved trials
Back to results
Completed
Phase 2
Phase 3
Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Patients With Metastatic Breast Cancer: Duration of Effect
NCT01344967
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
St. Michael's Hospital
Toronto, Ontario, Canada
View on ClinicalTrials.gov
Official details
Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Patients With Metastatic Breast Cancer: Duration of Effect — TrialFind